>
Switch to:

Altamira Therapeutics Net Margin %

: 0.00% (As of Jun. 2021)
View and export this data going back to 2014. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Altamira Therapeutics's Net Income for the six months ended in Jun. 2021 was $-7.44 Mil. Altamira Therapeutics's Revenue for the six months ended in Jun. 2021 was $0.00 Mil. Therefore, Altamira Therapeutics's net margin for the quarter that ended in Jun. 2021 was 0.00%.

The historical rank and industry rank for Altamira Therapeutics's Net Margin % or its related term are showing as below:

NAS:CYTO' s Net Margin % Range Over the Past 10 Years
Min: -6984.28   Med: -4712.64   Max: -4712.64
Current: -6984.28

-6984.28
-4712.64

NAS:CYTO's Net Margin % is ranked lower than
99.99% of the 268 Companies
in the Biotechnology industry.

( Industry Median: -333.16 vs. NAS:CYTO: -6984.28 )

Altamira Therapeutics Net Margin % Historical Data

The historical data trend for Altamira Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -4,712.64

Altamira Therapeutics Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -3,185.06 -

Competitive Comparison

For the Biotechnology subindustry, Altamira Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Altamira Therapeutics Net Margin % Distribution

For the Biotechnology industry and Healthcare sector, Altamira Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Altamira Therapeutics's Net Margin % falls into.



Altamira Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Altamira Therapeutics's Net Margin for the fiscal year that ended in Dec. 2020 is calculated as

Net Margin=Net Income (A: Dec. 2020 )/Revenue (A: Dec. 2020 )
=-9.2300765420982/0.19585772174696
=-4,712.64 %

Altamira Therapeutics's Net Margin for the quarter that ended in Jun. 2021 is calculated as

Net Margin=Net Income (Q: Jun. 2021 )/Revenue (Q: Jun. 2021 )
=-7.4410663141661/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Altamira Therapeutics  (NAS:CYTO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Altamira Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Altamira Therapeutics Business Description

Altamira Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Traded in Other Exchanges
Address
8 The Green, Suite 12455, Dover, DE, USA, 19901
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)